These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 436362

  • 1. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ, Amsterdam JD, Mendels J, Stern SL.
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [Abstract] [Full Text] [Related]

  • 2. Targeting imipramine dose in children with depression.
    Sallee F, Stiller R, Perel J, Rancurello M.
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of serum levels of imipramine and desipramine and individualization of dose in enuretic children.
    de Gatta MF, García MJ, Acosta A, Rey F, Gutierrez JR, Dominguez-Gil A.
    Ther Drug Monit; 1984 Jul; 6(4):438-43. PubMed ID: 6515703
    [Abstract] [Full Text] [Related]

  • 4. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J, Wasieczko A.
    Psychiatr Pol; 1991 Jul; 25(1):54-60. PubMed ID: 1780375
    [Abstract] [Full Text] [Related]

  • 5. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE, Biggs JT, Rosen SH, Meyer DA, Preskorn SH.
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [Abstract] [Full Text] [Related]

  • 6. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
    Mavissakalian MR, Perel JM.
    Psychopharmacol Bull; 1996 Aug; 32(1):143-7. PubMed ID: 8927664
    [Abstract] [Full Text] [Related]

  • 7. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E, Arena A, Pisani F.
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [Abstract] [Full Text] [Related]

  • 8. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B, Holle L.
    Chronobiol Int; 1991 Jun; 8(3):176-85. PubMed ID: 1794155
    [Abstract] [Full Text] [Related]

  • 9. Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.
    Potter WZ, Zavadil AP, Kopin IJ, Goodwin FK.
    Arch Gen Psychiatry; 1980 Mar; 37(3):314-20. PubMed ID: 7362419
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J, Panas M, Chruściel W.
    Pol J Pharmacol Pharm; 1983 Mar; 35(2):151-7. PubMed ID: 6622297
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report.
    Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Shea C, Tabrizi MA, Stiller RL.
    J Am Acad Child Psychiatry; 1979 Mar; 18(4):616-27. PubMed ID: 541469
    [No Abstract] [Full Text] [Related]

  • 12. Imipramine blood levels and clinical outcome.
    Rigal JG, Albin HC, Duchier AR, D'Aulnay JM, Fenelon JH, Vincon GA, Demotes-Mainard FM.
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [Abstract] [Full Text] [Related]

  • 13. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [Abstract] [Full Text] [Related]

  • 14. Model for the kinetics of imipramine and its metabolites in adolescents.
    Dell RB, Hein K, Ramakrishnan R, Puig-Antich J, Cooper T.
    Ther Drug Monit; 1990 Sep; 12(5):450-9. PubMed ID: 2293407
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A, Johansson R.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Sep; 290(2-3):145-60. PubMed ID: 1102994
    [Abstract] [Full Text] [Related]

  • 16. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J, Albin H, França X, Vinçon G, Démotes-Mainard F.
    Ann Med Psychol (Paris); 1988 Sep; 146(8):764-72. PubMed ID: 3242402
    [No Abstract] [Full Text] [Related]

  • 17. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL, Jusko WJ.
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics of imipramine in children.
    Tamayo M, Fernández de Gatta MM, García MJ, Domínguez-Gil A.
    Eur J Clin Pharmacol; 1992 Apr; 43(1):89-92. PubMed ID: 1505617
    [Abstract] [Full Text] [Related]

  • 19. [Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
    Oliver-Marti n R, Buschsenschultz E, Pichot P, Boissier J.
    Psychopharmacologia; 1975 Apr; 41(2):187-95. PubMed ID: 1153607
    [Abstract] [Full Text] [Related]

  • 20. Active metabolites of imipramine and desipramine in man.
    Potter WZ, Calil HM, Sutfin TA, Zavadil AP, Jusko WJ, Rapoport J, Goodwin FK.
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.